Key statistics
As of last trade, Allurion Technologies Inc (ALUR:NYQ) traded at 0.4218, 36.06% above the 52 week low of 0.31 set on Nov 15, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.52 |
---|---|
High | 0.535 |
Low | 0.4001 |
Bid | 0.4218 |
Offer | 0.4348 |
Previous close | 0.5109 |
Average volume | 584.84k |
---|---|
Shares outstanding | 64.49m |
Free float | 47.70m |
P/E (TTM) | -- |
Market cap | 32.95m USD |
EPS (TTM) | -0.4745 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 17:40 GMT.
More ▼
- Allurion Reports Third Quarter 2024 Financial Results and Provides Business Update
- Allurion Presents Data From Largest Ever Real-World Experience of 19,428 Patients at The Obesity Society’s Annual Conference
- Allurion to Report Third Quarter 2024 Financial Results on November 13, 2024
- Allurion Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon
- Allurion Announces Publication of New Data Demonstrating Muscle Mass Preservation in Patients Experiencing 15% Weight Loss
- Allurion Announces Publication of Meta-Analysis Demonstrating the Safety and Effectiveness of the Allurion Program for Weight Loss
- Allurion Receives Continued Listing Standards Notice from NYSE
- Allurion Announces Publication of New Data Demonstrating Weight Loss in Adolescents Suffering from Obesity
- Allurion Announces the Appointment of Eli Lilly Veteran, Keith Johns, to Its Board of Directors
- Allurion Announces Publication of New Data Demonstrating Continued Weight Loss at One Year On the Allurion Program
More ▼